Home Cart Sign in  
Chemical Structure| 2139356-35-5 Chemical Structure| 2139356-35-5

Structure of AMPD2 inhibitor 1
CAS No.: 2139356-35-5

Chemical Structure| 2139356-35-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

AMPD2 inhibitor 1 is an adenosine monophosphate deaminase 2 (AMPD2) inhibitor, used in the research of sugar craving, salt craving, umami craving, and addictions including drug, tobacco, nicotine and alcohol addictions.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of AMPD2 inhibitor 1

CAS No. :2139356-35-5
Formula : C25H22N2O2
M.W : 382.45
SMILES Code : O=C(C1=CC=C(C2=CC=C(CN[C@@H](C3=C4C=CC=CC4=CC=C3)C)C=C2)N=C1)O
MDL No. :N/A

Safety of AMPD2 inhibitor 1

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00253929 Blood Flow in Healthy Voluntee... More >>rs Less << Not Applicable Completed - Netherlands ... More >> Radboud University Nijmegen Medical Centre Nijmegen, Gelderland, Netherlands, 6500HB Less <<
NCT00513110 Endotoxemia Phase 1 Completed - Netherlands ... More >> Radboud University Nijmegen Medical Centre Nijmegen, Gelderland, Netherlands, 6500 HB Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.61mL

0.52mL

0.26mL

13.07mL

2.61mL

1.31mL

26.15mL

5.23mL

2.61mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories